1. An evolved AAV variant enables efficient genetic engineering of murine T cells.
- Author
-
Nyberg, William A., Ark, Jonathan, To, Angela, Clouden, Sylvanie, Reeder, Gabriella, Muldoon, Joseph J., Chung, Jing-Yi, Xie, William H., Allain, Vincent, Steinhart, Zachary, Chang, Christopher, Talbot, Alexis, Kim, Sandy, Rosales, Alan, Havlik, L. Patrick, Pimentel, Harold, Asokan, Aravind, and Eyquem, Justin
- Subjects
- *
GENETIC engineering , *VIRAL tropism , *IMMUNOCOMPETENT cells , *T cells , *CYTOLOGY , *GENE targeting , *ADENO-associated virus - Abstract
Precise targeting of large transgenes to T cells using homology-directed repair has been transformative for adoptive cell therapies and T cell biology. Delivery of DNA templates via adeno-associated virus (AAV) has greatly improved knockin efficiencies, but the tropism of current AAV serotypes restricts their use to human T cells employed in immunodeficient mouse models. To enable targeted knockins in murine T cells, we evolved Ark313, a synthetic AAV that exhibits high transduction efficiency in murine T cells. We performed a genome-wide knockout screen and identified QA2 as an essential factor for Ark313 infection. We demonstrate that Ark313 can be used for nucleofection-free DNA delivery, CRISPR-Cas9-mediated knockouts, and targeted integration of large transgenes. Ark313 enables preclinical modeling of Trac -targeted CAR-T and transgenic TCR-T cells in immunocompetent models. Efficient gene targeting in murine T cells holds great potential for improved cell therapies and opens avenues in experimental T cell immunology. [Display omitted] • A murine T cell-specific AAV variant, Ark313, is discovered through AAV6 evolution • A genome-wide CRISPR screen identifies QA2 an essential factor for Ark313 transduction • Ark313 enables efficient transgene delivery and targeting of large DNA payloads • Trac targeting of a CAR outperforms semi-random integration in a solid tumor model By combining structure-guided evolution and genome-wide screening, this work identifies an adeno-associated virus and co-factor that enable gene targeting at high efficiencies in mouse T lymphocytes, thus opening the path for T cell manipulations in murine models. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF